A research group led by Professor MORI Yasuko (of the Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine) has revealed that the HHV-6B glycoprotein complex gH/gL/gQ1/gQ2 is an effective vaccine candidate for human herpesvirus 6B (HHV-6B). There are still no methods to treat nor prevent HHV-6B infection, and this study represents the first attempt in the world at developing a vaccine.
- ‘Best’ hospitals should be required to deliver tobacco treatment
- Suspension of fertility treatments during COVID-19 has mental health impacts
- 40% of O’ahu, Hawai’i beaches could be lost by mid-century
- E. coli bacteria offer path to improving photosynthesis
- Hyperbolic metamaterials exhibit 2T physics